Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Northwestern University
National Institutes of Health Clinical Center (CC)
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Beth Israel Deaconess Medical Center
Alliance for Clinical Trials in Oncology